Stock Comparison
ALNY vs VRTX
Alnylam Pharmaceuticals Inc and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$38.90B
$124.70B
P/E (TTM)
73.0
29.2
Forward P/E
31.3
25.8
Price/Sales
9.1
10.2
Price/Book
36.2
6.4
EV/EBITDA
42.9
24.0
Dividend Yield
—
—
Profitability
Net Margin
12.60%
35.50%
Operating Margin
23.00%
38.10%
Return on Equity
90.40%
24.20%
Return on Assets
10.10%
12.10%
Growth (YoY)
Revenue Growth
96.40%
7.80%
Earnings Growth
0.00%
61.40%
Price & Risk
Beta
0.3
0.3
52-Week High
$495.55
$507.92
52-Week Low
$273.11
$362.50
Analyst Target
$436.32
$548.69
Compare ALNY and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.